Context Capital Management’s Cerevel Therapeutics Holdings CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-270,000
Closed -$2.82M – 270
2020
Q3
$2.82M Buy
+270,000
New +$2.85M 0.61% 62

Other funds holding CERE

Context Capital Management's CERE Position: Q4 2020 in Review

Context Capital Management sold out of Cerevel Therapeutics Holdings (CERE) in Q4 2020, closing a stake of 270,000 shares — an estimated $2.82M sold.

Context Capital Management first reported a position in CERE in Q3 2020 and held it in 1 quarter. The position peaked at $2.82M in Q3 2020. 58 funds tracked by Wall St. Rank hold CERE as of Q4 2020.

  • Context Capital Management reported no remaining Cerevel Therapeutics Holdings position as of Q4 2020 after selling out during the quarter.
  • Context Capital Management sold 270,000 Cerevel Therapeutics Holdings shares in Q4 2020, an estimated $2.82M.
  • Context Capital Management first reported a position in Cerevel Therapeutics Holdings in Q3 2020 and held it in 1 quarter.
  • Context Capital Management's Cerevel Therapeutics Holdings position peaked at $2.82M in Q3 2020.
  • 58 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings as of Q4 2020.

Based on Context Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.